Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
Author(s) -
Priyathama Vellanki,
Saumeth Cardona,
Rodolfo J. Galindo,
Maria A. Urrutia,
Francisco J. Pasquel,
Georgia M. Davis,
Maya Fayfman,
Alexandra L. Migdal,
Limin Peng,
Guillermo E. Umpierrez
Publication year - 2022
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc21-1606
Subject(s) - medicine , insulin , bedtime , hypoglycemia , diabetes mellitus , glycemic , type 2 diabetes , bolus (digestion) , intensive care , endocrinology , randomized controlled trial , gastroenterology , intensive care medicine
Administration of supplemental sliding scale insulin for correction of hyperglycemia in non-intensive care unit (ICU) patients with type 2 diabetes is frequently used with basal-bolus insulin regimens. In this noninferiority randomized controlled trial we tested whether glycemic control is similar with and without aggressive sliding scale insulin treatment before meals and bedtime in patients treated with basal-bolus insulin regimens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom